Combining assays may identify patients at higher risk and lead to earlier treatment.

Low Bacteroidetes levels may suggest higher disease activity as in Crohn and other inflammatory diseases.

Regulatory questions shed uncertainty on molecular imaging and diagnostic radiopharmaceutical industry.

According to our 2017 Technology Survey, half of physicians don't understand demonstrating IT use under Medicare payment reform. Here's what to know.

A study looking at care process, access, administrative efficiency, and outcomes ranks U.S. healthcare system last across the board.